Methods and devices for providing prolonged drug therapy

Details Methods and devices for providing prolonged drug therapy Methods and devices for providing prolonged drug therapy

2005-08-16

2005-08-16

Fay, Zohreh (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

Reexamination Certificate

active

06930129

ABSTRACT:
Methods and devices for maintaining a desired therapeutic drug effect over a prolonged therapy period are provided. In particular, oral dosage forms that release drug within the gastrointestinal tract at an ascending release rate over an extended time period are provided. The dosage forms may additionally comprise an immediate-release dose of drug.

REFERENCES:
patent: 2507631 (1950-05-01), Hartmann et al.
patent: 2648609 (1953-08-01), Wurster
patent: 2668162 (1954-02-01), Lowe
patent: 2676945 (1954-04-01), Higgins
patent: 2738303 (1956-03-01), Blythe
patent: 2798053 (1957-07-01), Brown
patent: 2799241 (1957-07-01), Wurster
patent: 2909462 (1959-10-01), Warfield et al.
patent: 2957880 (1960-10-01), Rometsch
patent: 2996431 (1961-08-01), Barry
patent: 3139383 (1964-06-01), Neville, Jr.
patent: 3625214 (1971-12-01), Higuchi
patent: 3773919 (1973-11-01), Boswell et al.
patent: 3811444 (1974-05-01), Heller et al.
patent: 3825068 (1974-07-01), Norton et al.
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 3962414 (1976-06-01), Michaels
patent: 3992518 (1976-11-01), Chien et al.
patent: 4036228 (1977-07-01), Theeuwes
patent: 4063064 (1977-12-01), Saunders et al.
patent: 4066747 (1978-01-01), Capozza
patent: 4070347 (1978-01-01), Schmitt
patent: 4079038 (1978-03-01), Choi et al.
patent: 4083949 (1978-04-01), Benedikt
patent: 4088864 (1978-05-01), Theeuwes et al.
patent: 4093709 (1978-06-01), Choi et al.
patent: 4111201 (1978-09-01), Theeuwes
patent: 4111202 (1978-09-01), Theeuwes
patent: 4137300 (1979-01-01), Sheth et al.
patent: 4200098 (1980-04-01), Ayer et al.
patent: 4285987 (1981-08-01), Ayer et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4434153 (1984-02-01), Urquhart et al.
patent: 4449983 (1984-05-01), Cortese et al.
patent: 4519801 (1985-05-01), Edgren
patent: 4612008 (1986-09-01), Wong et al.
patent: 4721613 (1988-01-01), Urquhart et al.
patent: 4752470 (1988-06-01), Mehta
patent: 4783337 (1988-11-01), Wong et al.
patent: 4814181 (1989-03-01), Jordan et al.
patent: 4853229 (1989-08-01), Theeuwes
patent: 5017381 (1991-05-01), Maruyama et al.
patent: 5030456 (1991-07-01), Ayer et al.
patent: 5082668 (1992-01-01), Wong et al.
patent: 5089270 (1992-02-01), Hampton et al.
patent: 5094786 (1992-03-01), Nagashima et al.
patent: 5178866 (1993-01-01), Wright et al.
patent: 5294770 (1994-03-01), Riddle et al.
patent: 5399828 (1995-03-01), Riddle et al.
patent: 5422831 (1995-06-01), Misra et al.
patent: 5464631 (1995-11-01), Hoover et al.
patent: 5484607 (1996-01-01), Horacek
patent: 5512593 (1996-04-01), Dante
patent: 5558231 (1996-09-01), Weier
patent: 5707663 (1998-01-01), Ayer et al.
patent: 5718700 (1998-02-01), Edgren et al.
patent: 5770227 (1998-06-01), Dong
patent: 5785994 (1998-07-01), Wong et al.
patent: 5824338 (1998-10-01), Jacobs et al.
patent: 5837284 (1998-11-01), Mehta et al.
patent: 5869097 (1999-02-01), Wong et al.
patent: 5874090 (1999-02-01), Baker et al.
patent: 675379 (1966-05-01), None
patent: 1 169 090 (1984-06-01), None
patent: 0 094 123 (1983-11-01), None
patent: 0 212 747 (1987-03-01), None
patent: 0 216 743 (1987-04-01), None
patent: 0 348 808 (1990-01-01), None
patent: 2 635 460 (1990-02-01), None
patent: 0 381 219 (1990-08-01), None
patent: 0 621 032 (1994-10-01), None
patent: 2 598 319 (1987-05-01), None
patent: 2 620 025 (1988-09-01), None
patent: 1113860 (1965-12-01), None
patent: 2 206 046 (1988-12-01), None
patent: 2 206 047 (1988-12-01), None
patent: 91/03247 (1991-03-01), None
patent: 92/01445 (1992-02-01), None
patent: 92/04012 (1992-03-01), None
patent: 92/18102 (1992-10-01), None
patent: WO93/05769 (1993-04-01), None
patent: 95/19174 (1995-07-01), None
patent: 95/20946 (1995-08-01), None
patent: WO98/06380 (1998-02-01), None
patent: 98/06380 (1998-02-01), None
patent: 98/14168 (1998-04-01), None
patent: 98/14168 (1998-04-01), None
patent: 98/23263 (1998-06-01), None
patent: 99/62496 (1999-12-01), None
Drill, Pharmacology in Medicine, pp. 227 (1965) McGraw-Hill.
Merck Index, 11thEdition, pp. 960, Item 6025 (1989).
Pharmaceutical Sciences by Remington, 17thed., pp. 342-345 (1985).
Pharmaceutical Sciences by Remington, 17thed., pp. 1603-1632 (1985).
Pharmaceutical Sciences by Remington, 17thed., Ch. 68, pp. 1305-1306 (1985).
Journal of the American Pharmaceutical Association, vol. 48, pp. 451-454 (1959).
Journal of the American Pharmaceutical Association, vol. 49, pp. 83-84 (1960).
Grafton, P./Boonton Molding Co., Modern Plastic Encyclopedia, vol. 46, pp. 62-70 (1969).
Wurster, Dale E., The Pharmacological Basis of Therapeutics by Goodman and Gilman, 7thed., Ch. 23, p. 534 (1940).
Pharmaceutical Sciences, Remington, 14thEd., pp. 1626-1679 (1970).
Patrick, K. S. et al, “The absorption of sustained-release methylphenidals formulations compared to an immediate-release formulation,”Biopharm Drug Dispos, 1989, 1, 165-171.
Park, K. et al., “Use of a Pharmacokinetic/Pharmacodynamic Model to Design an Optimal Dose Input Profile” ,Journal of Pharmacokinetics and Biopharmaceutics, 1998, 26(4), 471-492.
Hubbard, J. W. et al., “Enantioselective Aspects of the Disposition of dl-threo-Methylphenidate after the Administration of a Sustained-Release Formulation to Children with Attention Deficit-Hyperactivity Disorder,”Journal of Pharmaceutical Sciences, Nov. 1989, 78(11), 944-947.
S. Budavari, Ed., “,” The Merck Index, 12th ed., Merck Research Laboratories (New Jersey, U.S.A.), p. 1042, (Apr. 5, 1996).
Unknown, “Product Information,” Physicians' Desk Reference, Medical Economics Data (U.S.A.), p. 865-866, (Apr. 5, 1991).
J. R. Dipalma, Ed., “The Alcohols,” Drill's Pharmacology in Medicine, 3rd ed., McGraw-Hill Book Company (U.S.A.), p. 227.
Goodman & Gilman, “,” Pharma. Basis of Therapeutics, 8th ed., Pergamon Press (U.S.A.), p. 72.
R. E. King and J. B. Schwartz, “Oral Solid Dosage Forms,” Remington, Pharm. Sci., p. 1603-1632, (Apr. 5, 1985).
Roff et al., “Cellulose Ethers (I),” Handbook of Common Polymers, CRC Press (U.S.A.), p. 164-173, (Apr. 5, 1971).
M. A. Longer & J. R. Robinson, “Sustained-Release Drug Delivery Systems,” p. 1676-1686.
Voigt, R.:“Therapeutische Systeme.” Pharmazeutische Technologie, 1993, pp. 556-557.

Affiliated with

Also associated with

Rating

Methods and devices for providing prolonged drug therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and devices for providing prolonged drug therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and devices for providing prolonged drug therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3463261